FV-082: A safer orally active broad-spectrum antiepileptic drug candidate
Epilepsy & Behavior(2015)
摘要
Broad-spectrum antiepileptic drugs (AEDs) are valued for their potential to treat refractory epilepsy and, as general ‘neurostabilizers’, have been employed for a variety of neurological diseases including migraine, bipolar disorder, and neuropathic pain. However, the benefits of historical AEDs have been constrained by unintended CNS side effects. Combining proprietary breakthrough chemistry with Fluorinov Pharma and NIH's in vivo phenotypic screening strategy identified three completely novel candidate drugs, including FV-082, with superior safety and efficacy profiles.
更多查看译文
关键词
antiepileptic drug candidate,broad-spectrum
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要